Presentation is loading. Please wait.

Presentation is loading. Please wait.

Interesting Case Rounds July 31, 2008 Sean Caine CCFP-EM Resident.

Similar presentations

Presentation on theme: "Interesting Case Rounds July 31, 2008 Sean Caine CCFP-EM Resident."— Presentation transcript:

1 Interesting Case Rounds July 31, 2008 Sean Caine CCFP-EM Resident

2 The Case 90 d F referred from urgent care for FTT and prolonged jaundice


4 History

5 Pregnancy Mother was 23 yo Caucasian female G1P0 O neg Routine serology was normal GBS negative Nonsmoker. No EtOH Uncomplicated pregnancy (no PIH or GDM) Delivery 39wks GA ROM x 3 hrs BW=3220 Apgar 9 1,9 5 DAT negative Newborn metabolic screen was normal Tbili at discharge =190 d/c home 24hrs postpartum

6 History Followed by GP qweekly x 6 wks Jaundiced noted again at 6wk follow up with maternity care clinic 1 oz wt loss in past month Exclusively breast fed. Feeds well. ~6-8 BM/day. Stools are typically yellow. Recently have become more pale. ~6-8 wet diapers/day. Urine is brown. ROS otherwise unremarkable for sleep, appetite, activity, or symptoms indicative of focus for infection etc

7 On exam VS: /47 36 No apparent distress. Awake. Alert. Interactive and pleasant ++scleral icterus. +jaundice Firm liver edge. Palpable spleen tip. CV, Resp, CNS, Abdo exam otherwise unremarkable

8 Labs/Investigations

9 CBC Hb 110 (90-140) WBC 21.5 H (5-19.5) Plt 569 H ( ) Neut 9.2 H (1-9) Lytes, Cr, Urea – NORMAL Urinalysis/R&M LARGE Leuks, SMALL blood WBC/hpf 0-5 RBC Few bacteria LFT/enzymes Tbili 178 H (0-23) Direct bili 118 H (0-7) ALT 199 H (1-35) AST 262 H (10-65) ALP 461 H (40-390) GGT 796 H (8-35) Albumin 38 INR 1.1 PTT 40.5 H (27-36) Ammonia 61 H (12-47)

10 Objectives Review features of physiologic and pathologic jaundice Review approach to neonatal cholestasis Highlight some common pitfalls Return to the case to review the work up and diagnosis

11 Hyperbilirubinemia Has increasingly become a presenting complaint to ER due to early postpartum discharge However, still rare to encounter in Calgary ER Screened by PHN/GP in first 3-5 days postpartum Direct admit to PLC Unit 31 for assessment +/- phototherapy

12 Hyperbilirubinemia

13 Physiologic vs. Pathologic Jaundice in the Newborn

14 Physiologic vs. Pathologic Jaundice in the Newborn 1 Physiologic Unconjugated hyperbilirubinmia 60% term & >80% preterm neonates in first week Rises at rate <85 umol/L/day Appears on 2 nd or 3 rd day of life Typically peaks btwn days 2-4 Begins to decline on days 5-7 at rate of 34 umol/L/day Pathologic Appears <24 hrs Excessive for infants age (Tbili > 205 umol/L) Elevated direct bilirubin Jaundice present at or beyond 3 wks Sick infant Tbili rising >85 umol/L/day Unexplained jaundice following phototherapy Jaundice in the presence of risk factors

15 Ddx Conjugated vs. Unconjugated Hyperbilirubinemia UNCONJUGATEDCONJUGATED PhysiologicPathologic Non-hemolytic Cephalohematoma Polycythemia Sepsis Hypothyrodism Gilberts Crigler- Najjar Hemolytic Intrinsic Membrane Spherocytosis Elliptocytosis Enzyme G6PD PK deficiency Hemoglobin Alpha thal Hemolytic Extrinsic Immune ABO-incompatibility Rh-incompatibility Kelly-Duffy etc Non immune Splenomegaly Sepsis AV malformation Hepatic Infectious Sepsis Hep B, TORCH Metabolic Galactosemia Tyrosinemia Alpha-1-antitrypsin Hypothyroidism CF Drugs TPN Idiopathic neonatal Cholestasis Bile duct paucity AbN Bile acid metabolism Extra Hepatic Biliary atresia Choledocal cyst

16 Ddx of Hyperbilirubinemia According to Time of Onset First 24 hours24-72 hours72-96 hours> 1 week Often pathologic Hemolysis (Rh or ABO) Sepsis (GBS, TORCH) Cephalohematoma Spherocytosis Hemorrhagic disease of the newborn Physiologic Polycythemia Dehydration Hemolysis G6PD PK def Cephalohematoma Spherocytosis Sepsis/TORCH Physiologic Dehydration Sepsis Gilberts Crigler-Najjar Hypoxia/resp distress/hypoG Often pathologic Breast milk jaundice Prolonged Physiologic Hypothyroidism Neonatal Hepatitis Galactosemia Familial Cholestasis Biliary atresia Paucity of bile ducts

17 Neonatal Cholestasis Defined as the impaired canalicular biliary flow resulting in acumulation of biliary substances (bilirubin, bile acids, and cholesterol) 2 Estimated incidence of 1/2500 live births Jaundice at 2-3 weeks of age increases suspicion % of newborns are jaundice at 2 weeks of age 6 Estimated that jaundiced infants at 2 weeks of age would need to be tested to detect one case of cholestasis 2 6

18 Common Pitfalls Breast feeding jaundice Exaggeration of physiologic jaundice Day 2 7 Premature babies: can last up to 10 days Breast milk jaundice 2% of breast fed babies Starts ~ day 7, persists until week 2-3 May persist for 3-10 weeks at low levels Unconjugated Theory: glucuronidase in breast milk increased enterohepatic bilirubin re-circulation

19 Neonatal Cholestasis Clinical Presentation Prolonged jaundice Pale stools Dark urine Coagulopathy Hepatomegaly Splenomegaly RUQ mass FTT Less specific suggestive of underlying metabolic, CNS, or infectious aetiology: Fever Irritability Lethargy, Seizures Poor feeding Dysmorphic features

20 Ddx Neonatal Cholestasis Obstruction Biliary Atresia Choledochol cyst Tumor Inspissated bile/plug sybdrome Gallstone Biliary Sludge Infectious Bacterial Protozoal TORCH Echovirus Adenovirus Parvovirus B18 Metabolic/Genetic Alagille Syndrome α-1-Antitrypsin Galactosemia Tyrisonemia Lipid metabolism disorders Bilae acid metabolism disorders Mitochondrial Disease Citrin deficiancy

21 Approach to Neonatal Cholestasis 1. Initial investigations: Establish cholestasis and determine severity of disease Detailed hx, exam Fractioned serum bili Tests for liver injury (AST, ALT, ALP, GGT) LFT (Albumin, INR, PTT, serum ammonia, glucose) 2. Detect conditions that require immediate treatment CBC, blood & urine cultures to r/o sepsis Serum T4 and TSH Metabolic Screen: lactate, ammonia, iron, ferritin, urinalysis, urine amino acids and organic acids Viral serologies, VDRL, and cultures

22 Approach to Neonatal Cholestasis 3. Differentiate extrahepatic disorders from intrahepatic causes of cholestasis U/S Hepatobiliary scintigraphy Perc liver bx, Exploratory laparotomy with intraoperative 4. Establish other specific diagnosis α-1-antitrypsin, CF, Alagille, PFIC, storage disorders

23 Back to the Case 1. Initial investigation: establish cholestasis 2. Detect conditions that require treatment 3. Differentiate extrahepatic disorders from intrahepatic causes of cholestasis 4. Investigate for the rare diagnosis

24 BiliaryAtresia Inflammation of bile ducts leading to progressive obliteration of the extrahepatic biliary tract Most common cause of cholestasis in the first few weeks of life Incidence of 1/10,000 to 1/20,000 births Cause remains unknown though various infectious (CMV, reovirus, rotavirus) and genetic causes have been proposed

25 Biliary Atresia Jaundice typically develops in weeks 3-6 Uncommon for jaundice to be present at birth 10-15% association with congenital malformations (polysplenia, malrotation, etc)

26 Biliary Atresia Diagnosis U/S can be suggestive Liver biopsy is the most useful test HIDA useful Specificity improved with phenobarb 5d before scan Duodenal aspirate Exploratory laparotomy & intraoperative cholangiogram ERC and MRC likely to have future

27 Ultrasound Main utility is to r/o other extrahepatic causes (ie choledochol cyst) Findings suggestive of biliary atresia Absence of gallbladder Abnormal gallbladder size and shape Triangular cord sign Absence of a common bile duct

28 Ultrasound

29 Abnormally small and contracted gallbladder and irregular contour and septations in the gallbladder neck. Common bile duct not visualized Consistent with biliary atresia

30 Biliary Atresia Treatment Primary treatment is Kasai procedure Early diagnosis and surgery is critical Narrow window for optimal short and longterm outcomes bile drainage achieved in >80% of patients 90 days 4 yr survival with native liver 49% with sx <30 days of age 36% with sx at days of age 23% with sx at >90 days of age

31 Kasai

32 Pearls Recognize pathologic features of jaundice Obtain fractioned serum bili level (ie total and direct) on all 2-3 week old jaundiced infants Infants with biliary atresia will often appear to be well in the first 1-2 weeks of life Neonatal cholestasis is rare, but timely diagnosis is crucial!

33 References 1. Subcommittee on Hyperbilirubinemia. Management of Hyperbilirubinemia in the Newborn Infant 35 or More weeks of Gestation. Pediatrics. 2004;114: Venigalla S, Gourley GR. Neonatal Cholestasis. Seminars in Perinatology.2004;28: Suchy F. Neonatal Cholestasis. Pediatrics in Review. 2004;25: Schreiber RA, Barker CC, Roberts EA, et al. Biliary Atresia: the Canadian Experience. Journal of Pediatrics. 2007;151: Abrams S, Shulman R. Causes of Neonatal Cholestasis. UpToDate. Last updated June 12, Abrams S, Shulman R. Approach to Neonatal Cholestasis. UpToDate. Last updated September 26, 2006.

34 The End

Download ppt "Interesting Case Rounds July 31, 2008 Sean Caine CCFP-EM Resident."

Similar presentations

Ads by Google